Considering the link between hepatocyte lipotoxicity and liver fibrosis in NASH prognosis, we subsequently defined the association between TCF4- and MAFK-sensitive genes and human NASH at different stages of fibrosis. Here, TCF4 is linked to metabolic dysfunction-associated steatohepatitis.